KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Profit After Tax (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Profit After Tax for 11 consecutive years, with -$22.5 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax fell 343.72% to -$22.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$60.5 million through Dec 2025, down 41.84% year-over-year, with the annual reading at -$60.5 million for FY2025, 41.69% down from the prior year.
  • Profit After Tax hit -$22.5 million in Q4 2025 for Fulgent Genetics, down from -$6.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $200.7 million in Q1 2021 to a low of -$128.1 million in Q4 2023.
  • Historically, Profit After Tax has averaged $18.8 million across 5 years, with a median of -$10.3 million in 2023.
  • Biggest five-year swings in Profit After Tax: skyrocketed 10360.28% in 2021 and later crashed 1102.68% in 2023.
  • Year by year, Profit After Tax stood at $103.7 million in 2021, then plummeted by 122.99% to -$23.8 million in 2022, then tumbled by 437.72% to -$128.1 million in 2023, then skyrocketed by 96.04% to -$5.1 million in 2024, then plummeted by 343.72% to -$22.5 million in 2025.
  • Business Quant data shows Profit After Tax for FLGT at -$22.5 million in Q4 2025, -$6.8 million in Q3 2025, and -$19.3 million in Q2 2025.